The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}

INTRODUCTION: Hypertension increases the risk of cardiovascular disease. Uncontrolled nocturnal blood pressure is prevalent in patients taking antihypertensive medication, with an incidence rate of 30–60%. Although chronotherapy with antihypertensive agents may provide a new direction for effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mengzhuo, Zhang, Xin, Ye, Runyu, Liu, Xueting, Sun, Lirong, Jia, Shanshan, Zhang, Zhipeng, Li, Xinran, Wang, Ziqiong, Liao, Hang, Shi, Rufeng, Liu, Kai, Wang, Si, Meng, Qingtao, Chen, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685633/
https://www.ncbi.nlm.nih.gov/pubmed/38017457
http://dx.doi.org/10.1186/s13063-023-07726-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685633/
https://www.ncbi.nlm.nih.gov/pubmed/38017457
http://dx.doi.org/10.1186/s13063-023-07726-x

Ejemplares similares